The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism
Abstract
Hypercoagulability due to high coagulation factors XI, VIII, IX, II, and fibrinogen is recognized as a risk factor of venous thromboembolism (VTE). These factors are cumulatively explored by the activated partial thromboplastin time (APTT). To test the hypothesis that a short APTT increases the risk of VTE, a case-control study was carried out in 605 patients referred for thrombophilia testing after documented VTE and in 1290 controls. Median APTT ratio (coagulation time of test-to-reference plasma) values were 0.97 (range: 0.75-1.41) for patients and 1.00 (range: 0.72-1.33) for controls (P < .001). In patients who had an APTT ratio smaller than the fifth percentile of the distribution in controls, the odds ratio (OR) for VTE was 2.4 (95% confidence interval [CI]: 1.7-3.6) and was independent of inherited thrombophilic abnormalities. Further statistical analyses in 193 patients and 259 controls for whom factor VIII (FVIII) levels were available showed a decrease of the OR from 2.7 (95% CI: 1.4-5.3) to 2.1 (95% CI: 1.0-4.2), indicating that the risk was only partially mediated by high FVIII levels. In conclusion, hypercoagulability detected by a shortened APTT is independently associated with VTE. This inexpensive and simple test should be considered in the evaluation of the risk of VTE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., & Eichinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430702 · Cited by 763
ten Boekel, E., & Bartels, P. (2002) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000065217 · Cited by 51
Cited by
Epidemiology of venous thromboembolism
Heit, J. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.83 · Cited by 1,277
Venous thromboembolism: disease burden, outcomes and risk factors
HEIT, J. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01415.x · Cited by 447
Heit, J. A. (2006) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-006-5572-y · Cited by 383
ten Boekel, E., Böck, M., Vrielink, G.-J., Liem, R., Hendriks, H., & Kieviet, W. D. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.05.006 · Cited by 40
Short-term effect of dark chocolate consumption on routine haemostasis testing
Montagnana, M., Danese, E., Salvagno, G. L., & Lippi, G. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1268101 · Cited by 7
“ous thromboembolism (Tripodi et al. 2004), acute coronary syndrome (Madi et al.”
Background
Metadata
- Authors
- Tripodi, A., Chantarangkul, V., Martinelli, I., Bucciarelli, P., & Mannucci, P. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-12-01
- Volume
- 104
- Issue
- 12
- Pages
- 3631-3634
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2074475417
- Cited by
- 231
- References
- 3
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. https://app.cochat.ai/papers/10.1182/blood-2004-03-1042
- The paper
- Tripodi, A., Chantarangkul, V., Martinelli, I., Bucciarelli, P., & Mannucci, P. M. (2004). A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood. https://doi.org/10.1182/blood-2004-03-1042
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.